Ambev SA
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|.lR | LOCK|%<T | LOCK|B<%Pc^d |
Ambev Earnings: Encouraging Performance Despite Damped Volumes
Wide-moat AmBev reported its third-quarter 2024 results, which were in line with our expectations for revenue and profitability. Similar to AB InBev, AmBev saw a decline in organic total volume in the quarter, however we were encouraged by the firm's normalized EBITDA growth. We expect the firm will deliver overall top-line growth as well as gross and EBITDA margin expansion for 2024. However, we remain wary of weakness in certain markets weighing on results. With our long-term forecasts unchanged, we maintain our fair value estimate of BRL 18 per share and continue to view the stock as undervalued.
